In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The closing price of Idexx Laboratories, Inc. (NASDAQ: IDXX) was $468.04 for the day, down -5.02% from the previous closing price of $492.76. In other words, the price has decreased by -$5.02 from its previous closing price. On the day, 1.02 million shares were traded. IDXX stock price reached its highest trading level at $485.0 during the session, while it also had its lowest trading level at $462.0.
Ratios:
Our analysis of IDXX’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 85.67 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.32. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.51. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.49.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $602.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 06 ’24 when POLEWACZYK JAMES F sold 8,104 shares for $558.44 per share. The transaction valued at 4,525,596 led to the insider holds 10,711 shares of the business.
Vandebroek Sophie V. sold 1,404 shares of IDXX for $790,427 on Mar 05 ’24. The Director now owns 1,216 shares after completing the transaction at $562.98 per share. On Feb 08 ’24, another insider, FENNELL GEORGE, who serves as the SVP, Chief Revenue Officer of the company, sold 8,198 shares for $573.87 each. As a result, the insider received 4,704,559 and left with 6,712 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IDXX now has a Market Capitalization of 38872641536 and an Enterprise Value of 41556545536. As of this moment, Idexx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.51, and their Forward P/E ratio for the next fiscal year is 36.77. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.62 while its Price-to-Book (P/B) ratio in mrq is 26.18. Its current Enterprise Value per Revenue stands at 11.351 whereas that against EBITDA is 34.287.
Stock Price History:
Over the past 52 weeks, IDXX has reached a high of $583.39, while it has fallen to a 52-week low of $372.50. The 50-Day Moving Average of the stock is -11.54%, while the 200-Day Moving Average is calculated to be -7.09%.
Shares Statistics:
IDXX traded an average of 427.23K shares per day over the past three months and 551480 shares per day over the past ten days. A total of 83.03M shares are outstanding, with a floating share count of 82.27M. Insiders hold about 0.99% of the company’s shares, while institutions hold 89.82% stake in the company. Shares short for IDXX as of 1713139200 were 1711390 with a Short Ratio of 4.01, compared to 1710460800 on 1803921. Therefore, it implies a Short% of Shares Outstanding of 1711390 and a Short% of Float of 2.6400002.
